BioRestorative Therapies(BRTX) - 2025 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | Nevada | 30-1341024 | | --- | --- | | (State or other Jurisdiction of | (I.R.S. Employer | | Incorporation or Organization) | Identification No.) | 40 Marcus Drive, Melville, New York 11747 (Address of Principal Executive Offices) (Zip Code) (631) 760-8100 For the Quarterly Period Ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT ...